Kun-Der Lin

Kun-Der Lin


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2018 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
KLKun-Der Lin
Kun-Der Lin
GCGuei-Fen Chiu
Guei-Fen Chiu
AWAkbar K. Waljee
Akbar K. Waljee
SOStephanie Y. Owyang
Stephanie Y. Owyang
MEMohamad El-Zaatari
Mohamad El-Zaatari
JKJohn Y. Kao
John Y. Kao

Verified
Journal Article
Open access
PDF file
CLChing-Chao Liang
Ching-Chao Liang
PLPi-Chen Lin
Pi-Chen Lin
Mei Yueh LeeMei Yueh Lee
Mei Yueh Lee
SCSzu-Chia Chen
Szu-Chia Chen
SSShyi-Jang Shin
Shyi-Jang Shin
WHWei Hao Hsu
Wei Hao Hsu
Patients with type 2 diabetes mellitus (DM) may experience chronic microvascular complications such as diabetic retinopathy (DR) and diabetic nephropathy (DN) during their lifetime. In clinical studies, serum uric acid concentration has been found to be associated with DR and DN. The goal of this study was to evaluate the relationship between the increases in serum uric acid level and the severity of DR and albuminuria in Taiwanese patients with type 2 DM. We recorded serum uric acid concentration, the severity of DR, and the severity of albuminuria by calculating urinary albumin-to-creatinine ratio (UACR) in 385 patients with type 2 DM. In multivariate logistic regression analysis, a high uric acid concentration was a risk factor for albuminuria (odds ratio (OR), 1.227; 95% confidence interval (CI) = 1.015–1.482; p = 0.034) and DR (OR, 1.264; 95% CI = 1.084–1.473; p = 0.003). We also demonstrated that there was a higher concentration of serum uric acid in the patients with more severe albuminuria and DR. In conclusion, an increased serum uric acid level was significantly correlated with the severity of albuminuria and DR in Taiwanese patients with type 2 DM.

29 July 2016 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
KLKun-Der Lin
Kun-Der Lin
CYChun‐Yuh Yang
Chun‐Yuh Yang
MLMei‐Yueh Lee
Mei‐Yueh Lee
SHShu‐Chen Ho
Shu‐Chen Ho
CLChing‐Kuan Liu
Ching‐Kuan Liu
SSShyi-Jang Shin
Shyi-Jang Shin

16 October 2017 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
DHDer-Wei Hwu
Der-Wei Hwu
KLKun-Der Lin
Kun-Der Lin
KLKun-Chen Lin
Kun-Chen Lin
YLYau-Jiunn Lee
Yau-Jiunn Lee
YCYu-Hung Chang
Yu-Hung Chang
The aim of this systematic review and meta-analysis was to summarize the association of obstructive sleep apnea (OSA) with renal outcome. Our study followed the PRISMA guidelines. Two independent reviewers searched for relevant articles in the databases of Pubmed, the Web of Science and CENTRAL, and conducted study selection and quality assessment. A random-effect model was used to estimate the effects. A total of 1240 articles were initially identified (Pubmed = 568, Web of Science = 640, CENTRAL = 32). After removal of duplicate articles (n = 415) and irrelevant articles (n = 788), 37 were selected for full-text review, and 18 were finally included in the analysis. Overall, patients diagnosed with OSA were found to have a higher odds ratio (OR) of a poorer renal outcome, with a pooled OR of 1.77 (95% C.I.: 1.37–2.29). The significant association between OSA and a poorer renal outcome was not affected by the medical condition of diabetes mellitus (DM). In addition, we found that OSA was consistently associated with higher albuminuria/proteinuria and a lower estimated glomerular filtration rate (eGFR), with a pooled OR of 1.84 (95% C.I.: 1.24–2.73) and 1.60 (95% C.I.: 1.19–2.16), respectively. A greater OSA severity was also found to be related to a higher OR, with a mild group OR of 1.45 (95% C.I.: 1.19–1.77) and a moderate and severe group OR of 2.39 (95% C.I.: 1.96–2.90). Our study demonstrated that OSA is significantly associated with poorer renal function.

16 September 2021 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
PDF file
JWJun-Sing Wang
Jun-Sing Wang
YFYen Fu-Shun
Yen Fu-Shun
KLKun-Der Lin
Kun-Der Lin
SSShyi-Jang Shin
Shyi-Jang Shin
YHYueh-Han Hsu
Yueh-Han Hsu
D(Diabetes Kidney Disease Research Committee of the Diabetes Association of the Republic of China (Taiwan)
Diabetes Kidney Disease Research Committee of the Diabetes Association of the Republic of China (Taiwan)
Diabetic kidney disease (DKD) is a critical microvascular complication of diabetes. With the continuous increase in the prevalence of diabetes since 2000, the prevalence of DKD has also been increasing in past years. The prevalence of DKD among individuals with type 2 diabetes in Taiwan increased from 13.32% in 2000 to 17.92% in 2014. The cumulative incidence of DKD among individuals with type 1 diabetes in Taiwan was higher than 30% during 1999–2012. DKD is the leading cause of end‐stage renal disease (ESRD), with a prevalence of approximately 45% in a population on chronic dialysis in Taiwan. Among individuals with type 2 diabetes, the prevalence of ESRD in the receipt of dialysis also increased from 1.32% in 2005 to 1.47% in 2014. Risk factors for DKD development are age, race, family history, hyperglycemia, hypertension, dyslipidemia, dietary patterns, and lifestyles. Prognostic factors that aggravate DKD progression include age, family history, sex, glycemic control, blood pressure (BP), microvascular complications, and atherosclerosis. This review summarizes updated information on the onset and progression of DKD, particularly in the Taiwanese population. Translating these epidemiological features is essential to optimizing the kidney care and improving the prognosis of DKD in Asian populations.

1 November 2019 in Journal of the Formosan Medical Association
Verified
Journal Article
Open access
KLKun-Der Lin
Kun-Der Lin
CHChih-Cheng Hsu
Chih-Cheng Hsu
HOHorng-Yih Ou
Horng-Yih Ou
CWChi-Chuan Wang
Chi-Chuan Wang
MCMing-Chu Chin
Ming-Chu Chin
SSShyi-Jang Shin
Shyi-Jang Shin
Patients with diabetes have a higher risk of developing chronic complications and cause a huge burden to the public health care system as well as on patients and their families. We studied these diabetic complications about kidney, eye and peripheral vascular diseases to understand their prevalence and distributions in a national survey. We analyzed diabetic complications using National-Health-Insurance claims filed from 2005 to 2014. We used this database to evaluate their developments of kidney, eye, and peripheral vascular diseases according to the International-Classification-of-Diseases, Ninth Revision using clinical modification diagnosis codes. The prevalence of diabetic kidney disease (DKD) significantly increased from 10.49% to 17.92% from 2005 to 2014. The prevalence rate of diabetic foot significantly decreased from 1.34% to 1.05% from 2005 to 2014, and the rate of severe infection also significantly decreased from 50.69% to 45.85%. The amputation rate significantly decreased from 24.91% to 17.47% among all patients with diabetic foot. In this study, the trends in DKD and dialysis prevalence were similar to those of the 2012 report. The rate of increase in dialysis prevalence is lower in this study than in the 2012 report. The prevalence of diabetic foot, severe infection, and amputation in this report exhibited significantly decreasing trends. This improvement may be attributable to care from multidisciplinary teams. We should dedicate more resources to our prevention program of DKD and retinopathy to further improve outcomes in the future.